The chief executive officer of Rocket Pharmaceuticals, Gaurav Shah, MD, discussed the company’s ex-vivo and in-vivo gene therapy platforms.
Gaurav Shah, MD
Advertisement
Cofounder and chief executive officer, Rocket Pharmaceuticals
Articles by Gaurav Shah, MD
The chief executive officer of Rocket Pharmaceuticals, Gaurav Shah, MD, discussed the company’s lead programs and future plans.
Advertisement
Latest Updated Articles
Advantages of Developing Platform-Agnostic Gene TherapiesPublished: November 24th 2021 | Updated:
Advertisement
Advertisement
Trending on CGTlive®
1
Naji Gehchan, MD, MBA, on Evaluating CAR-T KYV-101 for Generalized Myasthenia Gravis
2
Around the Helix: Cell and Gene Therapy Company Updates – October 29, 2025
3
Quarter Century Update: Thoughts on Reducing Costs of Goods
4
Quarter Century Update: Future Predictions for the Field
5
